BlueCrest Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-26,255
Closed -$458K 1123
2019
Q1
$458K Buy
+26,255
New +$458K 0.02% 516